Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_1
1
11%
Ph phase_3
1
11%
Ph phase_4
4
44%

Phase Distribution

1

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 44 (44.4%)
N/A3 (33.3%)

Trials by Status

unknown444%
terminated111%
completed444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9